OBJECTIVE: We studied the longitudinal association between adiponectin and cardiac structure and function 10 years later stratified by hypertension status. METHODS: Multicenter longitudinal study of black and white men and women that began in 1985-1986, when participants were 18-30 years old. Adiponectin was measured at year 15(2000-2001). Echocardiograms were completed at year 25(2010-2011). Participants were stratified by the presence of hypertension. Risk factor-adjusted echocardiographic variables were compared across adiponectin quintiles. Linear and quadratic regression models were also derived for risk factor-adjusted echocardiographic variables. RESULTS: Relative to the lowest quintile of adiponectin, participants from the highest quintile had a 6% lower LV mass index (LVMi) among normotensives, and an 8% higher LVMi among hypertensives. Among normotensive participants, regression analysis demonstrated a linear inverse relationship between adiponectin and LV mass, LVMi, posterior wall thickness (PWT) and ventricular septal thickness (VST) (all p≤0.05). Among hypertensive participants, regression analysis demonstrated a U-shaped relationship between adiponectin and LV mass, LVMi, PWT and VST (p≤0.005 for all quadratic terms). CONCLUSIONS: Among normotensive participants, higher adiponectin may be a useful marker of less adverse future cardiac structure. Further study is required to see if adiponectin receptor agonists may provide a benefit among these individuals. Among hypertensive participants, further study is required to assess the prognostic and therapeutic use of adiponectin.
OBJECTIVE: We studied the longitudinal association between adiponectin and cardiac structure and function 10 years later stratified by hypertension status. METHODS: Multicenter longitudinal study of black and white men and women that began in 1985-1986, when participants were 18-30 years old. Adiponectin was measured at year 15(2000-2001). Echocardiograms were completed at year 25(2010-2011). Participants were stratified by the presence of hypertension. Risk factor-adjusted echocardiographic variables were compared across adiponectin quintiles. Linear and quadratic regression models were also derived for risk factor-adjusted echocardiographic variables. RESULTS: Relative to the lowest quintile of adiponectin, participants from the highest quintile had a 6% lower LV mass index (LVMi) among normotensives, and an 8% higher LVMi among hypertensives. Among normotensive participants, regression analysis demonstrated a linear inverse relationship between adiponectin and LV mass, LVMi, posterior wall thickness (PWT) and ventricular septal thickness (VST) (all p≤0.05). Among hypertensive participants, regression analysis demonstrated a U-shaped relationship between adiponectin and LV mass, LVMi, PWT and VST (p≤0.005 for all quadratic terms). CONCLUSIONS: Among normotensive participants, higher adiponectin may be a useful marker of less adverse future cardiac structure. Further study is required to see if adiponectin receptor agonists may provide a benefit among these individuals. Among hypertensive participants, further study is required to assess the prognostic and therapeutic use of adiponectin.
Entities:
Keywords:
Adipokine; Adiponectin; Left Ventricular Mass; Remodeling
Authors: Julio A Chirinos; Patrick Segers; Marc L De Buyzere; Richard A Kronmal; Muhammad W Raja; Dirk De Bacquer; Tom Claessens; Thierry C Gillebert; Martin St John-Sutton; Ernst R Rietzschel Journal: Hypertension Date: 2010-05-10 Impact factor: 10.190
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa Journal: Biochem Biophys Res Commun Date: 1999-04-02 Impact factor: 3.575
Authors: Aurelian Bidulescu; Jiankang Liu; Solomon K Musani; Ervin R Fox; Tandaw E Samdarshi; Daniel F Sarpong; Viola Vaccarino; Peter W Wilson; Donna K Arnett; Rebecca Din-Dzietham; Herman A Taylor; Gary H Gibbons Journal: Circ Heart Fail Date: 2011-08-12 Impact factor: 8.790
Authors: Samuel S Gidding; Kiang Liu; Laura A Colangelo; Nakela L Cook; David C Goff; Stephen P Glasser; Julius M Gardin; Joao A C Lima Journal: Circ Cardiovasc Imaging Date: 2013-08-06 Impact factor: 7.792
Authors: Michael W Steffes; Myron D Gross; Pamela J Schreiner; Xinhua Yu; Joan E Hilner; Ronald Gingerich; David R Jacobs Journal: Ann Epidemiol Date: 2004-08 Impact factor: 3.797
Authors: Keyonna M King; Markisha Key-Hagan; Avni Desai; Tehani Mundy; Atinuke K Shittu; Lisa R Roberts; Simone Montgomery; Martina Clarke; Regina Idoate; Tzeyu L Michaud; Athena K Ramos; Sheritta Strong; Roland J Thorpe; Susanne B Montgomery Journal: Am J Mens Health Date: 2022 May-Jun
Authors: Jacob T Caldwell; Karissa M Dieseldorff Jones; Hyerim Park; Jose R Pinto; Payal Ghosh; Emily C Reid-Foley; Brody Ulrich; Michael D Delp; Brad J Behnke; Judy M Muller-Delp Journal: Am J Physiol Heart Circ Physiol Date: 2021-05-14 Impact factor: 5.125